JPRN-UMIN000001167招募中未知
Analysis of Rho kinase (ROCK) activity in subjects with cerebrocardiovascular risk factor - ROCK study
Department of cardiovascular physiology and medicine, Hiroshima university graduate school of biomedical science0 个研究点目标入组 1,000 人开始时间: 2008年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects without informed consent
研究者
相似试验
已完成
不适用
Analysis of Rho-associated kinase(ROCK) activity in human placenta and peripheral blood monocytes.pregnancy,pregnancy induced hypertension,intrauterin growth restrictionJPRN-UMIN000006096Department of obstetrics and gynecology,Hiroshima university of biomedical science200
已完成
不适用
The effect of Rho kinase inhibitor for the treatment of corneal endothelial dysfunction: the 2nd stepCorneal endothelial dysfunctionJPRN-UMIN000003625Department of Ophthalmology, Kyoto Prefectural University of Medicine20
已完成
2 期
Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALSAmyotrophic lateral sclerosis (ALS)G12.2Motor neuron diseaseDRKS00013948Georg-August-Universität Göttingen, Stiftung Öffentlichen Rechts, Universitätsmedizin Göttingen120
进行中（未招募）
1 期
Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALSAmyotrophic lateral sclerosisMedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-003676-31-FRGeorg-August-Universität Göttingen120
尚未招募
不适用
se of Anti glaucoma eyedrop Ripasudil for treatment of corneal edema caused by cataract surgeryCTRI/2022/03/041064Office of Director General Armed Forces Medical Services